Orion Infusion Limited (DSE: ORIONINFU)

Market Cap	7.71B
Revenue (ttm)	850.39M
Net Income (ttm)	42.70M
Shares Out	20.36M
EPS (ttm)	2.10
PE Ratio	180.45
Forward PE	n/a
Dividend	1.00 (0.26%)
Ex-Dividend Date	n/a

Volume	374,133
Open	358.70
Previous Close	349.40
Day's Range	358.70 - 379.90
52-Week Range	266.00 - 726.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About Orion Infusion

Orion Infusion Limited engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh. It offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; Metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd. and changed its name to Orion Infusion Limited in 1994. Orion Infusion Limited was incorporated in 1983 and is based in Dhaka, Banglades...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1983
• Employees: 764
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONINFU

Financial Performance

In 2023, Orion Infusion's revenue was 810.15 million, a decrease of -2.34% compared to the previous year's 829.57 million. Earnings were 41.90 million, a decrease of -2.15%.